The nature of innate and adaptive interleukin-17A responses in sham or bacterial inoculation.

PubWeight™: 0.78‹?›

🔗 View Article (PMC 3385032)

Published in Immunology on July 01, 2012

Authors

Deborah L W Chong1, Rebecca J Ingram, Daniel E Lowther, Roshell Muir, Shiranee Sriskandan, Daniel M Altmann

Author Affiliations

1: Section of Infectious Diseases & Immunity, Imperial College, Hammersmith Hospital, London Centre for Infection & Immunity, Queen's University, Belfast, UK.

Articles cited by this

A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res (2001) 124.61

Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol (1986) 35.41

The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell (2006) 33.94

Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res (2002) 28.38

Pathogenesis of group A streptococcal infections. Clin Microbiol Rev (2000) 15.35

Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J Exp Med (2001) 12.38

The differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammat. Nat Immunol (2008) 9.64

Management of sepsis. N Engl J Med (2006) 9.01

Induction and effector functions of T(H)17 cells. Nature (2008) 7.75

Innate IL-17-producing cells: the sentinels of the immune system. Nat Rev Immunol (2010) 6.88

Structure and signalling in the IL-17 receptor family. Nat Rev Immunol (2009) 6.38

Functional specialization of interleukin-17 family members. Immunity (2011) 5.36

Recognition of stress-induced MHC molecules by intestinal epithelial gammadelta T cells. Science (1998) 5.05

Apoptosis and caspases regulate death and inflammation in sepsis. Nat Rev Immunol (2006) 4.82

Interleukin-17 and lung host defense against Klebsiella pneumoniae infection. Am J Respir Cell Mol Biol (2001) 4.56

Resident Vdelta1+ gammadelta T cells control early infiltration of neutrophils after Escherichia coli infection via IL-17 production. J Immunol (2007) 4.11

CTLA-8, cloned from an activated T cell, bearing AU-rich messenger RNA instability sequences, and homologous to a herpesvirus saimiri gene. J Immunol (1993) 3.74

Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease. Immunology (2010) 3.51

Gammadelta T cells and the lymphoid stress-surveillance response. Immunity (2009) 3.23

Cellular effectors mediating Th17-dependent clearance of pneumococcal colonization in mice. J Clin Invest (2009) 3.16

IL-6 controls Th17 immunity in vivo by inhibiting the conversion of conventional T cells into Foxp3+ regulatory T cells. Proc Natl Acad Sci U S A (2008) 3.04

gammadelta T cells: an important source of IL-17. Curr Opin Immunol (2008) 3.03

Interleukin-17 in host defence against bacterial, mycobacterial and fungal pathogens. Immunology (2009) 2.92

Systemic inflammation after trauma. Injury (2007) 2.62

Adverse functions of IL-17A in experimental sepsis. FASEB J (2008) 2.60

IL-17A produced by gammadelta T cells plays a critical role in innate immunity against listeria monocytogenes infection in the liver. J Immunol (2008) 2.49

Bacterial superantigens. Clin Exp Immunol (2003) 2.42

Cytokine expression profile over time in severely burned pediatric patients. Shock (2006) 2.33

Cutting edge: re-evaluating the in vivo cytokine responses of CD8+ T cells during primary and secondary viral infections. J Immunol (2005) 2.22

IL-17 cytokine family. J Allergy Clin Immunol (2004) 2.20

Anti-tumor necrosis factor therapy in sepsis: update on clinical trials and lessons learned. Crit Care Med (2001) 1.96

The immunology of sepsis. J Pathol (2008) 1.90

Translational mini-review series on Th17 cells: function and regulation of human T helper 17 cells in health and disease. Clin Exp Immunol (2009) 1.78

Superantigens: microbial agents that corrupt immunity. Lancet Infect Dis (2002) 1.76

Multiple triggers of cell death in sepsis: death receptor and mitochondrial-mediated apoptosis. FASEB J (2007) 1.73

The interleukin-17 cytokine family: critical players in host defence and inflammatory diseases. Immunology (2011) 1.53

IL-17-producing gammadelta T cells. Eur J Immunol (2009) 1.50

IL-6 promotes NK cell production of IL-17 during toxoplasmosis. J Immunol (2010) 1.35

Cytokine expression profile over time in burned mice. Cytokine (2008) 1.28

Differential capability of human cutaneous dendritic cell subsets to initiate Th17 responses. J Immunol (2009) 1.16

Induction of TGF-beta1 and TGF-beta1-dependent predominant Th17 differentiation by group A streptococcal infection. Proc Natl Acad Sci U S A (2010) 1.12

Differential IL-23 requirement for IL-22 and IL-17A production during innate immunity against Salmonella enterica serovar Enteritidis. Int Immunol (2009) 1.09

Natural killer cells participate in bacterial clearance during septic peritonitis through interactions with macrophages. Shock (2003) 1.09

Depletion of NK cells in a murine polytrauma model is associated with improved outcome and a modulation of the inflammatory response. Shock (2008) 1.08

Streptococcus pyogenes: Insight into the function of the streptococcal superantigens. Int J Biochem Cell Biol (2006) 1.07

Contribution of natural killer cells to the pathogenesis of septic shock induced by Streptococcus pyogenes in mice. J Infect Dis (2005) 1.04

Activation of mouse liver natural killer cells and NK1.1(+) T cells by bacterial superantigen-primed Kupffer cells. Hepatology (1999) 1.00

Superantigenic Staphylococcus aureus stimulates production of interleukin-17 from memory but not naive T cells. Infect Immun (2009) 0.98

Commercial peptidoglycan preparations are contaminated with superantigen-like activity that stimulates IL-17 production. J Leukoc Biol (2007) 0.93

Innate lymphocyte subsets and their immunoregulatory roles in burn injury and sepsis. J Burn Care Res (2007) 0.92

Soluble M1 protein of Streptococcus pyogenes triggers potent T cell activation. Cell Microbiol (2007) 0.90

Bacterial sepsis and chemokines. Curr Drug Targets (2006) 0.88

Systemic IL-17 after severe injuries. Shock (2008) 0.88

Sexual dimorphism in superantigen shock involves elevated TNF-alpha and TNF-alpha induced hepatic apoptosis. Am J Respir Crit Care Med (2007) 0.88

A novel role for NKT cells in cutaneous wound repair. J Surg Res (2009) 0.84

Characterization of a conserved helper-T-cell epitope from group A Streptococcal M proteins. Infect Immun (1993) 0.83

Streptococcal toxic shock syndrome associated with marked gamma delta T cell expansion: case report. Clin Infect Dis (1996) 0.76

Articles by these authors

Th1 not Th17 cells drive spontaneous MS-like disease despite a functional regulatory T cell response. Acta Neuropathol (2013) 2.80

Specific C-terminal cleavage and inactivation of interleukin-8 by invasive disease isolates of Streptococcus pyogenes. J Infect Dis (2005) 1.91

Peptide immunotherapy in allergic asthma generates IL-10-dependent immunological tolerance associated with linked epitope suppression. J Exp Med (2009) 1.73

The IL-8 protease SpyCEP/ScpC of group A Streptococcus promotes resistance to neutrophil killing. Cell Host Microbe (2008) 1.68

Keratinocyte growth factor promotes epithelial survival and resolution in a human model of lung injury. Am J Respir Crit Care Med (2014) 1.51

Application of a rat model of streptococcal shock to evaluate on-line hemoperfusion and removal of circulating superantigens. Crit Care Med (2003) 1.51

Sodium chloride inhibits the suppressive function of FOXP3+ regulatory T cells. J Clin Invest (2015) 1.43

The bacterial superantigen streptococcal mitogenic exotoxin Z is the major immunoactive agent of Streptococcus pyogenes. J Immunol (2002) 1.24

The mechanism of superantigen-mediated toxic shock: not a simple Th1 cytokine storm. J Immunol (2005) 1.20

Emerging role of the interleukin-8 cleaving enzyme SpyCEP in clinical Streptococcus pyogenes infection. J Infect Dis (2009) 1.19

Superantigens and streptococcal toxic shock syndrome. Emerg Infect Dis (2003) 1.17

HLA-C and killer cell immunoglobulin-like receptor genes in idiopathic bronchiectasis. Am J Respir Crit Care Med (2005) 1.14

Chemokine-cleaving Streptococcus pyogenes protease SpyCEP is necessary and sufficient for bacterial dissemination within soft tissues and the respiratory tract. Mol Microbiol (2010) 1.09

Modified amino acid copolymers suppress myelin basic protein 85-99-induced encephalomyelitis in humanized mice through different effects on T cells. Proc Natl Acad Sci U S A (2004) 1.08

Guidelines for prevention and control of group A streptococcal infection in acute healthcare and maternity settings in the UK. J Infect (2011) 1.07

Roles of the alternative complement pathway and C1q during innate immunity to Streptococcus pyogenes. J Immunol (2006) 1.06

New understandings in Streptococcus pyogenes. Curr Opin Infect Dis (2011) 1.06

Differential effects of Gram-positive versus Gram-negative bacteria on NOSII and TNFalpha in macrophages: role of TLRs in synergy between the two. Br J Pharmacol (2006) 1.04

High incidence of spontaneous disease in an HLA-DR15 and TCR transgenic multiple sclerosis model. J Immunol (2005) 1.04

IL-9 regulates pathology during primary and memory responses to respiratory syncytial virus infection. J Immunol (2009) 1.04

Molecular analysis of an outbreak of lethal postpartum sepsis caused by Streptococcus pyogenes. J Clin Microbiol (2013) 1.04

Is selection for TCR affinity a factor in cytokine polarization? Trends Immunol (2002) 1.03

Inactivation of the CovR/S virulence regulator impairs infection in an improved murine model of Streptococcus pyogenes naso-pharyngeal infection. PLoS One (2013) 1.02

Natural exposure to cutaneous anthrax gives long-lasting T cell immunity encompassing infection-specific epitopes. J Immunol (2010) 1.02

Stat4-null non-obese diabetic mice: protection from diabetes and experimental allergic encephalomyelitis, but with concomitant epitope spread. Int Immunol (2005) 1.00

Impact of immunization against SpyCEP during invasive disease with two streptococcal species: Streptococcus pyogenes and Streptococcus equi. Vaccine (2009) 0.99

Role of Toll-like receptors 2 and 4 in the induction of cyclooxygenase-2 in vascular smooth muscle. Proc Natl Acad Sci U S A (2005) 0.99

Inhibition of macropinocytosis blocks antigen presentation of type II collagen in vitro and in vivo in HLA-DR1 transgenic mice. Arthritis Res Ther (2006) 0.99

HLA class II polymorphisms determine responses to bacterial superantigens. J Immunol (2004) 0.98

Elucidation of toll-like receptor and adapter protein signaling in vascular dysfunction induced by gram-positive Staphylococcus aureus or gram-negative Escherichia coli. Shock (2007) 0.98

Superantigen recognition by HLA class II on monocytes up-regulates toll-like receptor 4 and enhances proinflammatory responses to endotoxin. Blood (2005) 0.97

Toll-like receptor 2 is essential for the sensing of oxidants during inflammation. Am J Respir Crit Care Med (2008) 0.97

Gentamicin-loaded nanoparticles show improved antimicrobial effects towards Pseudomonas aeruginosa infection. Int J Nanomedicine (2012) 0.93

Disease-related epitope spread in a humanized T cell receptor transgenic model of multiple sclerosis. Eur J Immunol (2004) 0.93

In vivo enhancement of peptide display by MHC class II molecules with small molecule catalysts of peptide exchange. J Immunol (2009) 0.93

DQB1*0602 rather than DRB1*1501 confers susceptibility to multiple sclerosis-like disease induced by proteolipid protein (PLP). J Neuroinflammation (2012) 0.91

HLA-DR alleles in amyloid beta-peptide autoimmunity: a highly immunogenic role for the DRB1*1501 allele. J Immunol (2009) 0.90

The impact of glycosylation on HLA-DR1-restricted T cell recognition of type II collagen in a mouse model. Arthritis Rheum (2006) 0.90

HLA-DQB1*0602 determines disease susceptibility in a new "humanized" multiple sclerosis model in HLA-DR15 (DRB1*1501;DQB1*0602) transgenic mice. J Immunol (2009) 0.90

CD4 T cells selected by antigen under Th2 polarizing conditions favor an elongated TCR alpha chain complementarity-determining region 3. J Immunol (2002) 0.90

Immune responses and tolerance to the RhD blood group protein in HLA-transgenic mice. Blood (2004) 0.90

Current views of haemolytic streptococcal pathogenesis. Curr Opin Infect Dis (2014) 0.89

Charcot-Marie-Tooth disease associated with recurrent optic neuritis. J Clin Neurosci (2011) 0.88

Sexual dimorphism in superantigen shock involves elevated TNF-alpha and TNF-alpha induced hepatic apoptosis. Am J Respir Crit Care Med (2007) 0.88

Consensus on the development of vaccines against naturally acquired melioidosis. Emerg Infect Dis (2015) 0.88

The immune cell infiltrate populating meningiomas is composed of mature, antigen-experienced T and B cells. Neuro Oncol (2013) 0.87

Anthrax lethal toxin and the induction of CD4 T cell immunity. Toxins (Basel) (2012) 0.87

An anthrax subunit vaccine candidate based on protective regions of Bacillus anthracis protective antigen and lethal factor. Vaccine (2010) 0.87

A role of cellular prion protein in programming T-cell cytokine responses in disease. FASEB J (2009) 0.85

The cellular prion protein is preferentially expressed by CD4+ CD25+ Foxp3+ regulatory T cells. Immunology (2008) 0.85

Differential regulation of CCL-11/eotaxin-1 and CXCL-8/IL-8 by gram-positive and gram-negative bacteria in human airway smooth muscle cells. Respir Res (2008) 0.85

Pro-inflammatory mechanisms in sepsis. Contrib Microbiol (2011) 0.85

Scarlet Fever Upsurge in England and Molecular-Genetic Analysis in North-West London, 2014. Emerg Infect Dis (2016) 0.85

Non-invasive monitoring of Streptococcus pyogenes vaccine efficacy using biophotonic imaging. PLoS One (2013) 0.84

The TCR Vbeta signature of bacterial superantigens spreads with stimulus strength. Int Immunol (2006) 0.84

Repertoire of HLA-DR1-restricted CD4 T-cell responses to capsular Caf1 antigen of Yersinia pestis in human leukocyte antigen transgenic mice. Infect Immun (2010) 0.84

Humoral and cellular immunity to primary H1N1 infection in patients with hematologic malignancies following stem cell transplantation. Biol Blood Marrow Transplant (2010) 0.84

Peptide-induced immune regulation by a promiscuous and immunodominant CD4T-cell epitope of Timothy grass pollen: a role of Cbl-b and Itch in regulation. Thorax (2013) 0.83

Gram-positive and Gram-negative bacteria synergize with oxidants to release CXCL8 from innate immune cells. Mol Med (2008) 0.83

Polyfunctional CD4+ T cell responses to a set of pathogenic arenaviruses provide broad population coverage. Immunome Res (2010) 0.83

An epitope of Bacillus anthracis protective antigen that is cryptic in rabbits may be immunodominant in humans. Infect Immun (2010) 0.83

The serodominant secreted effector protein of Salmonella, SseB, is a strong CD4 antigen containing an immunodominant epitope presented by diverse HLA class II alleles. Immunology (2014) 0.82

C-terminal antibodies (CTAbs): a simple and broadly applicable approach for the rapid generation of protein-specific antibodies with predefined specificity. Proteomics (2007) 0.82

Pulmonary infection with Cryptococcus neoformans in the face of underlying sarcoidosis. Respiration (2005) 0.82

Increased surface toll-like receptor 2 expression in superantigen shock. Crit Care Med (2008) 0.81

Injectional anthrax infection due to heroin use induces strong immunological memory. J Infect (2014) 0.81

T cell responses to a non-glycosylated epitope predominate in type II collagen-immunised HLA-DRB1*0101 transgenic mice. Ann Rheum Dis (2006) 0.81

Innate immunity in multiple sclerosis white matter lesions: expression of natural cytotoxicity triggering receptor 1 (NCR1). J Neuroinflammation (2012) 0.80

Superantigens SPEA and SMEZ do not affect secretome expression in Streptococcus pyogenes. Microb Pathog (2008) 0.79

CD4+ T-cell immunity to the Burkholderia pseudomallei ABC transporter LolC in melioidosis. Eur J Immunol (2010) 0.79

Superantigenic activity of emm3 Streptococcus pyogenes is abrogated by a conserved, naturally occurring smeZ mutation. PLoS One (2012) 0.78

Chronic Infection by Mucoid Pseudomonas aeruginosa Associated with Dysregulation in T-Cell Immunity to Outer Membrane Porin F. Am J Respir Crit Care Med (2015) 0.78

Spread of T lymphocyte immune responses to myelin epitopes with duration of multiple sclerosis. J Neuropathol Exp Neurol (2005) 0.78

Impaired opsonization with complement and phagocytosis of Streptococcus pyogenes in sera from subjects with inherited C2 deficiency. Microbes Infect (2010) 0.77

Increased HLA-E expression in white matter lesions in multiple sclerosis. Immunology (2012) 0.77

Ebola and other viral haemorrhagic fevers: a local operational approach. Br J Hosp Med (Lond) (2014) 0.77

Correction: Elucidation of the RamA Regulon in Klebsiella pneumoniae Reveals a Role in LPS Regulation. PLoS Pathog (2016) 0.75

Comment on "Frequency of epitope-specific naive CD4+ T cells correlates with immunodominance in the human memory repertoire". J Immunol (2012) 0.75

Tuberculosis in London: not unexpected - Authors' reply. Lancet (2013) 0.75

Streptococcus pyogenes under pressure. Nat Med (2007) 0.75

The human prion protein residue 129 polymorphism lies within a cluster of epitopes for T cell recognition. J Neuropathol Exp Neurol (2006) 0.75

Corrigendum: Emergence of a novel lineage containing a prophage in emm/M3 group A Streptococcus associated with upsurge in invasive disease in the UK. Microb Genom (2016) 0.75

Rapid screen for epithelial internalization of Tn917-mutagenized Streptococcus pyogenes. J Microbiol Methods (2009) 0.75

Immune regulation in idiopathic bronchiectasis. Ann N Y Acad Sci (2012) 0.75